Archives

Market Updates

AstraZeneca Says Camizestrant Reduces Risk Of Disease Progression By 56% In SERENA-6 Phase III Trial

(RTTNews) - AstraZeneca PLC (AZN) announced positive results from the SERENA-6 Phase III trial, demonstrating that camizestrant, in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor, sign...

• June 01, 2025 07:39 AM PDT
• EODHD

Market Updates

Bessent says US will never default as Congress faces deadline

(Bloomberg) — Treasury Secretary Scott Bessent said the US “is never going to default” as the deadline for increasing the federal debt ceiling gets closer. Most Read from Bloomberg Billionaire Steve C...

• June 01, 2025 07:05 AM PDT
• EODHD

Market Updates

Will Tesla have to play catch up to Waymo's robotaxis?

Tesla (TSLA) looks to move into its "golden age," according to Wedbush analyst Dan Ives, through the rollout of its robotaxi beta in Austin, Texas, on June 12. Waymo — whose parent company is tech gia...

• June 01, 2025 07:00 AM PDT
• EODHD

Market Updates

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of respo...

• June 01, 2025 07:00 AM PDT
• EODHD